Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1996
12/10/1996US5583038 Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
12/10/1996US5583028 Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins
12/10/1996US5583014 Enzymatic digestion; cell-free antigenic solution useful in immunizing horses
12/10/1996US5583002 Determining the level of expression of at least one selected t-cell antigen receptor protein or a protein in the t-lymnphocyte signal transduction pathway
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease
12/10/1996US5582968 For immunoassay
12/10/1996US5582967 Human cell line LC5 and its use
12/10/1996US5582862 Administering to treat myocardial infarction or blood clot
12/10/1996US5582831 Anti-tumor vaccines
12/10/1996US5582829 Lyme disease
12/10/1996US5582827 Process of screening plasma samples for effective antibody titers against respiratory viruses
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/10/1996CA1338778C Stress proteins and uses therefor
12/10/1996CA1338777C Methods and compositions for preventing secondary cataracts
12/08/1996CA2178538A1 Hepatitis gb virus synthetic peptides and uses thereof
12/08/1996CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof
12/05/1996WO1996038588A1 Analytical and therapeutic agents
12/05/1996WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER
12/05/1996WO1996038557A1 Hepatocyte growth factor receptor antagonists and uses thereof
12/05/1996WO1996038543A1 Modified cells and methods for inhibiting xenograft rejection
12/05/1996WO1996038532A1 Coanda effect gene delivery instrument and method of use
12/05/1996WO1996038476A1 Haemophilus influenzae pilus vaccines
12/05/1996WO1996038475A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996WO1996038177A1 Mutants of salmonella typhi and uses thereof
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038161A1 Drug delivery enhancement via modified saponins
12/05/1996WO1996038136A1 Localized use of nitric oxide-adducts to prevent internal tissue damage
12/05/1996WO1996034884A3 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
12/05/1996DE19513595C1 Antikörper gegen Herzmuskel-Actin Antibodies against heart muscle actin
12/05/1996CA2223063A1 Drug delivery enhancement via modified saponins
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222797A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996CA2220648A1 Coanda effect gene delivery instrument and method of use
12/05/1996CA2217131A1 Modified cells and methods for inhibiting xenograft rejection
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745602A1 Quinidine immunoassay and reagents
12/04/1996EP0745390A2 Polymeric prodrugs for beta-lactamase and uses thereof
12/04/1996EP0745388A1 Mammalian vaccines composition comprising squalene or squalane, phospholipid and a surfactant as adjuvant
12/04/1996EP0745387A2 Adjuvants for viral vaccines
12/04/1996EP0745386A1 Anti-aids secretory recombinant bcg vaccine
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745133A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
12/04/1996EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745095A1 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744940A1 Drugs, vaccines and hormones in polylactide coated microspheres
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1136918A Single-shot vaccine formulation
12/03/1996US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses
12/03/1996US5580858 Immunosuppressive and tolerogenic modified Lewisx compounds
12/03/1996US5580778 Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
12/03/1996US5580774 Anticarcinogenic agents
12/03/1996US5580773 Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
12/03/1996US5580724 Sampling maternal blood, incubation in cytokines mixture of erythropoietin, stem cell factor, interleukins to stimulate fetal cell growth; noninvasive
12/03/1996US5580720 Human lymphoid cells expressing human immunodeficiency virus envelope protein gp160
12/03/1996US5580719 Isolating genomic rna from poliovirus, employing rna sequencing to determine nucleotide at position 2493
12/03/1996US5580575 Therapeutic drug delivery systems
12/03/1996US5580564 A pseudorabies virus having the replacement of the inducible promoter sequence of the immediate early gene to control tissue specificity; vaccines
12/03/1996US5580563 Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
12/03/1996US5580558 Delivery of gene products via mesangial cells
12/03/1996CA1338771C Adhesion receptor for laminin and its use
12/03/1996CA1338758C Process for the preparation of inducers of non-specific immunity
12/01/1996CA2177644A1 Polymeric prodrugs for beta-lactamase and uses thereof
12/01/1996CA2176417A1 Quinidine immunoassay and reagents
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines
11/28/1996WO1996037623A1 Retroviral vectors
11/28/1996WO1996037606A1 Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv)
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037222A1 Vaccine composition containing polyribosylribitol phosphate and method for making same
11/28/1996WO1996037221A1 Subunit vaccine against flavivirus infection
11/28/1996WO1996037220A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
11/28/1996WO1996037219A1 Abundant extracellular products and methods for their production and use
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037211A1 Latent transcripts and promoters of cytomegalovirus
11/28/1996WO1996037208A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996WO1996037178A2 Novel method of enhancing efficiency of anti-arthropod agents against blood-feeding ectoparasites
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996WO1996022067A3 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
11/28/1996WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
11/28/1996DE19619255A1 Human cytomegalovirus peptide(s)
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221155A1 Cdna clone for south african arbovirus no. 86
11/28/1996CA2220971A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
1 ... 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 ... 1823